Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 9, 2021 - The drug shortage of Leadiant’s Cystaran (cysteamine) 0.44% ophthalmic solution is ongoing. Cystaran has been unavailable due to an independent manufacturer declaring bankruptcy.
Return to publications